Cathay Biotech Inc. (SHA:688065)

Cathay Biotech Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	10,797	5,347	5,390	6,295	9,629	5,710
Trading Asset Securities	0.47	0.47	0.47	0.47	0.47	1,330
Cash & Short-Term Investments	10,798	5,347	5,391	6,295	9,629	7,040
Cash Growth	116.46%	-0.81%	-14.37%	-34.62%	36.78%	474.40%
Accounts Receivable	516.05	459.88	385.52	463.56	275.22	294.95
Other Receivables	10.57	10.56	10.35	11.79	6.58	8.32
Receivables	526.62	470.43	395.88	475.35	281.8	303.27
Inventory	1,164	1,181	1,466	1,574	1,185	775.1
Prepaid Expenses	-	7.29	10.57	-	-	0.14
Other Current Assets	459.93	381.4	307.18	131.44	298.68	325.91
Total Current Assets	12,948	7,387	7,571	8,475	11,395	8,444
Property, Plant & Equipment	9,848	9,849	9,376	6,670	2,969	2,789
Long-Term Investments	156.66	133.78	142.73	49.51	53.21	56.18
Other Intangible Assets	692.97	685.04	703.85	777.87	768.46	228.44
Long-Term Deferred Tax Assets	220.61	210.37	158.88	88.28	52.2	36.65
Long-Term Deferred Charges	5.73	6.42	4.98	7.17	9.58	7.87
Other Long-Term Assets	818.56	750.4	876.48	1,759	938.51	572.25
Total Assets	24,690	19,021	18,833	17,827	16,185	12,135
Accounts Payable	1,370	135.44	167.85	240.08	248.83	205.25
Accrued Expenses	8.31	30.32	21.54	32.47	42.34	35.66
Short-Term Debt	640.11	1,247	746.25	161.47	743.51	-
Current Portion of Long-Term Debt	372.32	37.17	784.37	5.38	-	-
Current Income Taxes Payable	43.85	32.94	55.54	30.7	45.4	19.28
Current Unearned Revenue	36.61	35.81	10.48	17.81	14.64	19.9
Other Current Liabilities	67.77	1,399	1,624	936.28	123.01	154.68
Total Current Liabilities	2,538	2,918	3,410	1,424	1,218	434.77
Long-Term Debt	623.31	613.26	245.33	960.5	-	-
Long-Term Unearned Revenue	382.75	389.29	405.18	404.39	293.03	214.6
Long-Term Deferred Tax Liabilities	-	-	-	-	-	1.37
Total Liabilities	3,545	3,920	4,060	2,789	1,511	650.74
Common Stock	721.29	583.38	583.38	583.28	416.68	416.68
Additional Paid-In Capital	14,299	8,520	8,526	8,540	8,688	8,681
Retained Earnings	2,682	2,546	2,167	1,905	1,539	1,278
Treasury Stock	-155.13	-155.13	-126.19	-94.67	-	-
Comprehensive Income & Other	16.43	12.77	14.45	14.69	8.23	8.68
Total Common Equity	17,564	11,507	11,164	10,949	10,652	10,385
Minority Interest	3,582	3,594	3,609	4,089	4,022	1,100
Shareholders' Equity	21,145	15,101	14,773	15,038	14,674	11,484
Total Liabilities & Equity	24,690	19,021	18,833	17,827	16,185	12,135
Total Debt	1,636	1,897	1,776	1,127	743.51	-
Net Cash (Debt)	9,162	3,450	3,615	5,168	8,886	7,040
Net Cash Growth	177.19%	-4.56%	-30.05%	-41.84%	26.22%	660.78%
Net Cash Per Share	15.67	5.93	6.21	8.87	15.24	12.97
Filing Date Shares Outstanding	595.44	718.95	581.32	582.15	583.35	583.35
Total Common Shares Outstanding	595.44	582.75	581.68	582.15	583.35	583.35
Working Capital	10,409	4,469	4,161	7,051	10,177	8,010
Book Value Per Share	29.50	19.75	19.19	18.81	18.26	17.80
Tangible Book Value	16,871	10,822	10,460	10,171	9,883	10,156
Tangible Book Value Per Share	28.33	18.57	17.98	17.47	16.94	17.41
Buildings	-	1,958	1,815	1,357	988.18	599.56
Machinery	-	3,330	3,216	2,979	1,807	1,002
Construction In Progress	-	5,949	5,443	3,164	758.31	1,610

Source: S&P Global Market Intelligence. Standard template. Financial Sources.